Home >Archive

Volume: 3, Issue: 6, June, 2013
DOI: 10.7324/JAPS.2013.3617



Research Article

Design of dissolution media for in-vitro bioequivalence testing of Lamivudine

Nagiat T Hwisa, Shanta Kumari Adiki, Prakash Katakam and Babu Rao Chandu

  Author Affiliations


Abstract

The present investigation is aimed at developing the stability indicating dissolution media for the determination of lamivudine (3TC) in pharmaceutical dosage forms. The stability of 3TC was tested in various dissolution media maintained at ambient temperature and 37 oC for 48 hrs. Stability studies of 3TC in various media indicated that the drug was stable in 0.1M HCl, pH 1.2 KCl-HCl buffer, pH 6.2 and pH 7.0 phosphate buffers. The λmax were found to be 280.0, 278.8, 273.0 and 271.5nm for 0.1M HCl, pH 1.2 KCl-HCl buffer, pH 6.2 and pH 7.0 phosphate buffers respectively with low CV of <4.44%. The linearity of standard plots in optimized media was 0.5-40 µg/ml for 0.1M HCl and pH 1.2 KCl-HCl buffer. Similarly it was 0.5-60 µg/ml in pH 6.2 buffer and 0.2-40 µg/ml in pH 7.0 phosphate buffer. The validated methods were applied to determine 3TC concentration in formulations. In-vitro dissolution testing indicated that the 3TC was stable and drug release is uniform from tablet dosage forms. The optimized media could be employed to study the dissolution profiles of 3TC in bioequivalence studies.

Keywords:

Lamivudine, Stability indicating, Bioequivalence studies, Dissolution media.



Citation:


Copyright: The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

Article Metrics

Similar Articles

Hepatitis in Bangladesh: Pattern and treatment Options
Most. Nazma Parvin, Riaz Uddin and Sadia Afreen Chowdhury

Evaluation of Transdermal Formulations: A Technical Note
Mudasir Mohamad & Roheena Jan

Study of regulatory requirements for the conduct of bioequivalence studies in US, Europe, Canada, India, ASEAN and SADC countries: Impact on generic drug substitution
Nitika Kaushal, Sachin Kumar Singh, Monica Gulati, Yogyata Vaidya, Munish Kaushik